OpenURL Connection Search

Select item for more details and to access through your institution.

Allogeneic stem cell transplantation for sickle cell disease. A study of patients’ decisions.
Published in:
Bone Marrow Transplantation, 2001, v. 28, n. 6, p. 545, doi. 10.1038/sj.bmt.1703208
By:
- van Besien, K;
- Koshy, M;
- Anderson-Shaw, L;
- Talishy, N;
- Dorn, L;
- Devine, S;
- Yassine, M;
- Kodish, E
Publication type:
Article
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Published in:
Bone Marrow Transplantation, 2001, v. 28, n. 6, p. 557, doi. 10.1038/sj.bmt.1703198
By:
- Devine, S M;
- Sanborn, R;
- Jessop, E;
- Stock, W;
- Huml, M;
- Peace, D;
- Wickrema, A;
- Yassine, M;
- Amin, K;
- Thomason, D;
- Chen, Y-H;
- Devine, H;
- Maningo, M;
- van Besien, K
Publication type:
Article
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
Published in:
Bone Marrow Transplantation, 2001, v. 27, n. 4, p. 397, doi. 10.1038/sj.bmt.1702793
By:
- van Besien, K;
- Rodriguez, A;
- Tomany, S;
- Younes, A;
- Donato, M;
- Sarris, A;
- Giralt, S;
- Mehra, R;
- Andersson, B;
- Gajewski, J;
- Champlin, R;
- Cabanillas, F
Publication type:
Article
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 4, p. 445, doi. 10.1038/sj.bmt.1702518
By:
- van Besien, K;
- Bartholomew, A;
- Stock, W;
- Peace, D;
- Devine, S;
- Sher, D;
- Sosman, J;
- Chen, Y-H;
- Koshy, M;
- Hoffman, R
Publication type:
Article
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 3, p. 333, doi. 10.1038/sj.bmt.1702521
By:
- de Lima, M;
- van Besien, K;
- Gajewski, J;
- Khouri, I;
- Andersson, B;
- Korbling, M;
- Champlin, R;
- Giralt, S
Publication type:
Article
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Published in:
Bone Marrow Transplantation, 1999, v. 24, n. 7, p. 763, doi. 10.1038/sj.bmt.1701983
By:
- Przepiorka, D;
- Khouri, I;
- Ippoliti, C;
- Ueno, N T;
- Mehra, R;
- Körbling, M;
- Giralt, S;
- Gajewski, J;
- Fischer, H;
- Donato, M;
- Cleary, K;
- Claxton, D;
- Chan, K-W;
- Braunschweig, I;
- van Besien, K;
- Andersson, B S;
- Anderlini, P;
- Champlin, R
Publication type:
Article
Toxicity of single daily dose gentamicin in stem cell transplantation.
Published in:
Bone Marrow Transplantation, 1999, v. 24, n. 1, p. 57, doi. 10.1038/sj.bmt.1701831
By:
- Warkentin, D;
- Ippoliti, C;
- Bruton, J;
- Van Besien, K;
- Champlin, R
Publication type:
Article
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Published in:
Bone Marrow Transplantation, 1999, v. 23, n. 10, p. 977, doi. 10.1038/sj.bmt.1701764
By:
- Przepiorka, D;
- Khouri, I;
- Thall, P;
- Mehra, R;
- Lee, M-S;
- Ippoliti, C;
- Giralt, S;
- Gajewski, J;
- van Besien, K;
- Andersson, B;
- Körbling, M;
- Deisseroth, A B;
- Champlin, R
Publication type:
Article
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Published in:
Bone Marrow Transplantation, 1997, v. 20, n. 6, p. 491, doi. 10.1038/sj.bmt.1700910
By:
- Ippoliti, C;
- Morgan, A;
- Warkentin, D;
- van Besien, K;
- Mehra, R;
- Khouri, I;
- Giralt, S;
- Gajewski, J;
- Champlin, R;
- Andersson, B;
- Przepiorka, D
Publication type:
Article
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Published in:
Bone Marrow Transplantation, 1997, v. 19, n. 10, p. 977, doi. 10.1038/sj.bmt.1700781
By:
- van Besien, K. W.;
- de Lima, M.;
- Giralt, S. A.;
- Moore, Jr., D. F.;
- Khouri, I. F.;
- Rondón, G.;
- Mehra, R.;
- Andersson, B. S.;
- Dyer, C.;
- Cleary, K.;
- Przepiorka, D.;
- Gajewski, J. L.;
- Champlin, R. E.
Publication type:
Article
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Published in:
Bone Marrow Transplantation, 1997, v. 19, n. 5, p. 455, doi. 10.1038/sj.bmt.1700692
By:
- Przepiorka, D;
- Anderlini, P;
- Ippoliti, C;
- Khouri, I;
- Fietz, T;
- Thall, P;
- Mehra, R;
- Giralt, S;
- Gajewski, J;
- Deisseroth, A B;
- Cleary, K;
- Champlin, R;
- van Besien, K;
- Andersson, B;
- Körbling, M
Publication type:
Article
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphoma.
Published in:
Bone Marrow Transplantation, 1997, v. 19, n. 2, p. 121, doi. 10.1038/sj.bmt.1700614
By:
- de Lima, M;
- van Besien, K W;
- Giralt, S A;
- Khouri, I F;
- Mehra, R;
- Andersson, B S;
- Przepiorka, D;
- Gajewski, J L;
- Korbling, M;
- Champlin, R E
Publication type:
Article
Allogeneic and autologous transplantation for chronic lymphocytic leukemia.
Published in:
2001
By:
- van Besien, K;
- Keralavarma, B;
- Devine, S;
- Stock, W
Publication type:
journal article
Studies of decitabine with allogeneic progenitor cell transplantation.
Published in:
Leukemia (08876924), 1997, v. 11, p. S32
By:
- Giralt, S.;
- Davis, M.;
- O'Brien1, S.;
- van Besien, K.;
- Champlin, R.;
- D.de Vos;
- Kantarjian, H.
Publication type:
Article
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab.
Published in:
Clinical & Experimental Immunology, 2021, v. 203, n. 1, p. 96, doi. 10.1111/cei.13497
By:
- Elhadad, S.;
- Chapin, J.;
- Copertino, D.;
- Van Besien, K.;
- Ahamed, J.;
- Laurence, J.
Publication type:
Article
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 9, p. 1227, doi. 10.1038/bmt.2015.133
By:
- Yew, P Y;
- Alachkar, H;
- Yamaguchi, R;
- Kiyotani, K;
- Fang, H;
- Yap, K L;
- Liu, H T;
- Wickrema, A;
- Artz, A;
- van Besien, K;
- Imoto, S;
- Miyano, S;
- Bishop, M R;
- Stock, W;
- Nakamura, Y
Publication type:
Article
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 722, doi. 10.1038/bmt.2014.11
By:
- Gergis, U;
- Mayer, S;
- Gordon, B;
- Mark, T;
- Pearse, R;
- Shore, T;
- Van Besien, K
Publication type:
Article
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1437, doi. 10.1038/bmt.2013.79
By:
- Locke, F;
- Agarwal, R;
- Kunnavakkam, R;
- van Besien, K;
- Larson, R A;
- Odenike, O;
- Godley, L A;
- Liu, H;
- Le Beau, M M;
- Gurbuxani, S;
- Thirman, M J;
- Sipkins, D;
- White, C;
- Artz, A;
- Stock, W
Publication type:
Article
Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1455, doi. 10.1038/bmt.2012.57
By:
- Cook, R J;
- Wang, Z;
- Arora, M;
- Lazarus, H M;
- Kasow, K A;
- Champagne, M A;
- Saber, W;
- van Besien, K M;
- Hale, G A;
- Copelan, E A;
- Elmongy, M;
- Ueno, N T;
- Horn, B N;
- Slavin, S;
- Bishop, M R;
- Stadtmauer, E A
Publication type:
Article
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 2, p. 217, doi. 10.1038/bmt.2011.56
By:
- Marino, S R;
- Lin, S;
- Maiers, M;
- Haagenson, M;
- Spellman, S;
- Klein, J P;
- Binkowski, T A;
- Lee, S J;
- van Besien, K
Publication type:
Article
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.
Published in:
Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1692, doi. 10.1038/bmt.2010.32
By:
- Locke, F. L.;
- Artz, A.;
- Rich, E.;
- Zhang, Y.;
- van Besien, K.;
- Stock, W.
Publication type:
Article
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1068, doi. 10.1038/bmt.2009.307
By:
- Shaughnessy, P. J.;
- Bolwell, B. J.;
- van Besien, K.;
- Mistrik, M.;
- Grigg, A.;
- Dodds, A.;
- Prince, H. M.;
- Durrant, S.;
- Ilhan, O.;
- Parenti, D.;
- Gallo, J.;
- Foss, F.;
- Apperley, J.;
- Zhang, M.-J.;
- Horowitz, M. M.;
- Abhyankar, S.
Publication type:
Article
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Published in:
Bone Marrow Transplantation, 2008, v. 41, n. 6, p. 505, doi. 10.1038/sj.bmt.1705931
By:
- Kline, J.;
- Subbiah, S.;
- Lazarus, H. M.;
- van Besien, K.
Publication type:
Article
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 11, p. 1027, doi. 10.1038/sj.bmt.1705852
By:
- Pollyea, D. A.;
- Artz, A. S.;
- Stock, W.;
- Daugherty, C.;
- Godley, L.;
- Odenike, O. M.;
- Rich, E.;
- Smith, S. M.;
- Zimmerman, T.;
- Zhang, Y.;
- Huo, D.;
- Larson, R.;
- van Besien, K.
Publication type:
Article
Chimerism does not predict for outcome after alemtuzumab based conditioning.
Published in:
2007
By:
- Michaelis, L.;
- Lin, S.;
- Joseph, L.;
- Artz, A. S.;
- Kline, J.;
- Pollyea, D.;
- Stock, W.;
- Rich, E.;
- Collins-Jones, D.;
- Casey, B.;
- Cerro, P. Del;
- van Besien, K.
Publication type:
Letter
Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
Published in:
2006
By:
- Kline, J.;
- van Besien, K.;
- Nathanson, J.;
- Noffsinger, A.;
- Artz, A.
Publication type:
Letter
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Published in:
Bone Marrow Transplantation, 2006, v. 37, n. 3, p. 307, doi. 10.1038/sj.bmt.1705249
By:
- Kline, J.;
- Pollyea, D. A.;
- Stock, W.;
- Artz, A.;
- Rich, E.;
- Godley, L.;
- Zimmerman, T.;
- Thompson, K.;
- Pursell, K.;
- Larson, R. A.;
- van Besien, K.
Publication type:
Article
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 10, p. 965, doi. 10.1038/sj.bmt.1704938
By:
- Kebriaei, P;
- Kline, J;
- Stock, W;
- Kasza, K;
- Le Beau, M M;
- Larson, R A;
- van Besien, K
Publication type:
Article
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 3, p. 253, doi. 10.1038/sj.bmt.1704760
By:
- Artz, A S;
- Van Besien, K;
- Zimmerman, T;
- Gajewski, T F;
- Rini, B I;
- Hu, H S;
- Stadler, W M;
- Vogelzang, N J
Publication type:
Article
Stem cell transplantation in follicular lymphoma: progress at last?
Published in:
Bone Marrow Transplantation, 2004, v. 34, n. 11, p. 929, doi. 10.1038/sj.bmt.1704654
By:
- Tse, W. W.;
- Lazarus, H. M.;
- Van Besien, K.
Publication type:
Article
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 10, p. 1015, doi. 10.1038/sj.bmt.1704483
By:
- Popat, U.;
- Hosing, C.;
- Saliba, R. M.;
- Anderlini, P.;
- van Besien, K.;
- Przepiorka, D.;
- Khouri, I. F.;
- Gajewski, J.;
- Claxton, D.;
- Giralt, S.;
- Rodriguez, M.;
- Romaguera, J.;
- Hagemeister, F.;
- Ha, C.;
- Cox, J.;
- Cabanillas, F.;
- Andersson, B. S.;
- Champlin, R. E.
Publication type:
Article
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 5, p. 471, doi. 10.1038/sj.bmt.1704166
By:
- van Besien, K;
- Devine, S;
- Wickrema, A;
- Jessop, E;
- Amin, K;
- Yassine, M;
- Maynard, V;
- Stock, W;
- Peace, D;
- Ravandi, F;
- Chen, Y-H;
- Hoffman, R;
- Sossman, J
Publication type:
Article
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 1, p. 9, doi. 10.1038/sj.bmt.1704088
By:
- van Besien, K;
- Devine, S;
- Wickrema, A;
- Jessop, E;
- Amin, K;
- Yassine, M;
- Maynard, V;
- Stock, W;
- Peace, D;
- Ravandi, F;
- Chen, Y-H;
- Cheung, T;
- Vijayakumar, S;
- Hoffman, R;
- Sosman, J
Publication type:
Article
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
Published in:
Bone Marrow Transplantation, 2003, v. 31, n. 9, p. 813, doi. 10.1038/sj.bmt.1703916
By:
- Verma, A;
- Devine, S;
- Morrow, M;
- Chen, Y-H;
- Mihalov, M;
- Peace, D;
- Stock, W;
- Pursell, K;
- Wickrema, A;
- Yassine, M;
- Jessop, E;
- van Besien, K
Publication type:
Article
Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?
Published in:
Leukemia (08876924), 2005, v. 19, n. 1, p. 31, doi. 10.1038/sj.leu.2403594
By:
- van Besien, K;
- Artz, A;
- Stock, W
Publication type:
Article
Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
Published in:
Leukemia (08876924), 2003, v. 17, n. 1, p. 271, doi. 10.1038/sj.leu.2402735
By:
- Ravandi, F;
- van Besien, K
Publication type:
Article
MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 560, doi. 10.1002/hon.8_2632
By:
- Ruan, J.;
- Leonard, J.P.;
- Coleman, M.;
- Rutherford, S.;
- Van Besien, K.;
- Rodriguez, A.;
- Benderoff, L.;
- Mehta‐Shah, N.;
- Moskowitz, A.;
- Sokol, L.;
- Cerchietti, L.;
- Inghirami, G.;
- Martin, P.
Publication type:
Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
By:
- Jaeger, U.;
- Tam, C.;
- Borchmann, P.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Westin, J.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Schuster, S.;
- Bachanova, V.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
By:
- Bachanova, V.;
- Westin, J.;
- Tam, C.;
- Borchmann, P.;
- Jaeger, U.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Bishop, M.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 560, doi. 10.1002/hon.8_2632
By:
- Ruan, J.;
- Leonard, J.P.;
- Coleman, M.;
- Rutherford, S.;
- Van Besien, K.;
- Rodriguez, A.;
- Benderoff, L.;
- Mehta‐Shah, N.;
- Moskowitz, A.;
- Sokol, L.;
- Cerchietti, L.;
- Inghirami, G.;
- Martin, P.
Publication type:
Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
By:
- Jaeger, U.;
- Tam, C.;
- Borchmann, P.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Westin, J.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Schuster, S.;
- Bachanova, V.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
By:
- Bachanova, V.;
- Westin, J.;
- Tam, C.;
- Borchmann, P.;
- Jaeger, U.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Bishop, M.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
Exercise in patients receiving intensive cancer therapy.
Published in:
2007
By:
- Hacker E;
- Larson J;
- Peace D;
- Van Besien K
Publication type:
Journal Article

Found: 43